Intracoronary stenting without coumadin: one month results of a French multicenter study.

In order to simplify post-coronary stenting treatment and to obtain a lower rate of complications, especially in bailout situations, seven French institutions treated 246 stented patients with 0.25 g/day of ticlopidine, 0.1 g/day of IV aspirin, and 2 days of heparin followed by low-molecular-weight heparin for 1 month. Fifty percent of patients had a planned stenting procedure, and 50% had an unplanned procedure, including 29 (11.8%) in bailout situations. Subacute occlusion occurred in three (1.2%) patients (one death, two non-Q-wave infarctions). During the 1 month follow-up period, another death was reported (non-stent-related), two elective coronary artery bypass grafts were performed, and three additional patients presented with non-Q-wave myocardial infarctions. Nine (3.7%) patients had a groin complication that required blood transfusion or surgical repair. These results suggest that while waiting for the technological advancements of stents, postprocedural treatment that includes a low dosage of ticlopidine, aspirin, and low-molecular-weight heparin is a very effective alternative to conventional poststenting therapy.

[1]  P. Barragan,et al.  Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. , 1994, Catheterization and cardiovascular diagnosis.

[2]  Craig D. Miller,et al.  Management of Patients With Intramural Hematoma of the Thoracic Aorta , 1993, Circulation.

[3]  J. Douglas,et al.  Clinical and Angiographic Outcomes After Coronary Artery Stenting for Acute or Threatened Closure After Percutaneous Transluminal Coronary Angioplast Initial Results with a Balloon‐Expandable, Stainless Steel Design , 1993, Circulation.

[4]  E. Topol,et al.  Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. , 1993, Journal of the American College of Cardiology.

[5]  R. Erbel,et al.  Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. , 1993, American heart journal.

[6]  E. Topol,et al.  Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome. , 1993, Journal of the American College of Cardiology.

[7]  A. Buchwald,et al.  Platelet and fibrin deposition on coronary stents in minipigs: effect of hirudin versus heparin. , 1993, Journal of the American College of Cardiology.

[8]  Larry S. Dean,et al.  Intracoronary Stenting for Acute and Threatened Closure Complicating Percutaneous Transluminal Coronary Angioplasty , 1992, Circulation.

[9]  R A Schatz,et al.  Clinical experience with the Palmaz-Schatz coronary stent. , 1991, Journal of the American College of Cardiology.

[10]  V. Hachinski,et al.  THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.

[11]  R A Schatz,et al.  A view of vascular stents. , 1989, Circulation.

[12]  J. Rösch,et al.  Transluminal expandable nitinol coil stent grafting: preliminary report. , 1983, Radiology.

[13]  C. Stoddard,et al.  Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin. , 1981, The New England journal of medicine.

[14]  MacKenzie Iz.  Letter: Transcervical fetoscopy. , 1974 .

[15]  C. Dotter,et al.  Transluminally-placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. , 1969, Investigative radiology.

[16]  M. P. Judkins,et al.  Transluminal Treatment of Arteriosclerotic Obstruction: Description of a New Technic and a Preliminary Report of Its Application , 1964, Circulation.